AFNET – the Atrial Fibrillation NETwork

Physicians and scientists co-operate within the AFNET. A network is formed by hospitals and doctors’ offices – reaching from GPs to university hospitals.

Atrial Fibrillation – Information for Patients

Atrial Fibrillation is the most common arrhythmia of the heart – especially in elderly people. We inform you about the current treatment options.

Research – Clinical Trials on a European Level

Several million people in Europe live with atrial fibrillation. We investigate new treatment options. Within AFNET trials scientists co-operate on a European level.

Results – for a better treatment

New findings from AFNET trials flow into the clinical routine. AFNET experts develop recommendations for the therapy of atrial fibrillation.




[18.01.2016 ] Using catheter ablation to create complete linear lesions... [read more]
[19.10.2015 ] At least 30 million people worldwide live with atrial... [read more]
[19.06.2015 ] Today the 2000th patient has been enrolled in the EAST –... [read more]
[10.06.2015 ] The EAST - AFNET 4 trial was presented at the Annual... [read more]
[21.05.2015 ] Today, 21st May 2015 the CATCH ME (Characterizing Atrial... [read more]
[20.04.2015 ] The German Atrial Fibrillation Network (AFNET) has elected... [read more]
[02.03.2015 ] While NOACs are valid alternatives to vitamin K antagonist... [read more]
[19.05.2014 ] The treatment options for atrial fibrillation have been... [read more]
[20.12.2013 ] New classification comes after the first European... [read more]
[13.12.2013 ] The website of the German Competence Network on Atrial... [read more]